Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Paola Dorigo"'
Autor:
Vito Boido, Marcella Ercoli, Michele Tonelli, Federica Novelli, Bruno Tasso, Fabio Sparatore, Elena Cichero, Paola Fossa, Paola Dorigo, Guglielmina Froldi
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 32, Iss 1, Pp 588-599 (2017)
Positive inotropic agents are fundamental in the treatment of heart failure; however, their arrhythmogenic liability and the increased myocardial oxygen demand strongly limit their therapeutic utility. Pursuing our study on cardiovascular activities
Externí odkaz:
https://doaj.org/article/8a8b34dde1414dbf8e141cd391ec21a0
Autor:
Maura Floreani, Guglielmina Froldi, Maurizio Cavalli, Sergio Bova, Maria Cecilia Giron, Katia Varani, Stefania Gessi, Pier Andrea Borea, Maria Teresa Dorigo, Paola Dorigo
Publikováno v:
Journal of Pharmacological Sciences, Vol 95, Iss 1, Pp 115-123 (2004)
We evaluated in vitro, in myocardial and vascular preparations isolated from reserpine-treated rats, the intrinsic sympathomimetic activity (ISA) of carteolol, a β1/β2-adrenoceptor blocking agent used in cardiovascular and non-cardiovascular diseas
Externí odkaz:
https://doaj.org/article/86690e3457954e929bed479312e329ee
Autor:
Paola Dorigo, Guglielmina Froldi
Publikováno v:
Medical Hypotheses
Several risk factors are associated with a worse outcome for COVID-19 patients; the most recognized are demographic characteristics such as older age and male gender, and pre-existing cardiovascular conditions. About the latter, hypertension and coro
Autor:
Paola Dorigo, Michele Tonelli, Vito Boido, Marcella Ercoli, Fabio Sparatore, Bruno Tasso, Guglielmina Froldi, Paola Fossa, Federica Novelli, Elena Cichero
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 32, Iss 1, Pp 588-599 (2017)
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 32, Iss 1, Pp 588-599 (2017)
Positive inotropic agents are fundamental in the treatment of heart failure; however, their arrhythmogenic liability and the increased myocardial oxygen demand strongly limit their therapeutic utility. Pursuing our study on cardiovascular activities
Autor:
Paola Dorigo, F Lonardoni, Eugenio Ragazzi, Laura Caparrotta, Stefano Mammi, Guglielmina Froldi, Monica Montopoli, Massimo Bellanda
Publikováno v:
Current Cancer Drug Targets. 11:226-235
The way cancer cells escape cisplatin-induced apoptosis has not been completely elucidated yet. We questioned the relevance of "metabolic reprogramming" in cisplatin-resistance by studying mitochondrial function and metabolism in human ovarian carcin
Publikováno v:
Pharmacology. 81:70-78
The effects of 5-hydroxytryptamine (5-HT), 5-carboxamidotryptamine, and sumatriptan on rat caudal arteries were examined, with the goal of finding experimental conditions useful in enhancing the ‘silent’ 5-HT1B receptor subtype. It was shown that
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 367:109-118
Two mechanisms are responsible for the positive inotropic effect of the cardiotonic drug milrinone, i.e., inhibition of type III cAMP phosphodiesterase (PDE III), and displacement of endogenous adenosine from A(1) inhibitory receptor. Since PDE III i
Publikováno v:
British Journal of Pharmacology. 127:505-513
1. To investigate the role of endothelium in vascular spasm, we studied the influence of endothelin-1 (ET-1) on the contracting and spasmogenic effect of the K+-channel blocker, tetraethylammonium (TEA), in aorta rings of reserpine-treated guinea-pig
Publikováno v:
British Journal of Pharmacology. 121:972-976
Purine compounds such as ATP and adenosine, respectively endothelium-dependent and-independent vasodilators, are largely involved in the control of vascular tone and vascular reactivity to contracting stimuli. We investigated the relaxing activity of
Autor:
Maura Floreani, Paola Dorigo, Rosa Maria Gaion, P. A. Borea, Santostasi G, Luisa Mosti, I. Maragno, D. Fraccarollo
Publikováno v:
General Pharmacology: The Vascular System. 28:781-788
1. 1. Two new milrinone analogs, 3-acetyl-6-phenyl-2(IH)-pyridone (SF 348) and 3-acetyl-7-methyl-7,8-dihydro-2,5(1H, 6H) quinolinone (SF 349), increase the contractile activity of spontaneously beating and electrically driven atria isolated from rese